How GOAL.MD reviews and updates peptide evidence
The process behind the library, stated so it can be held to.
Why this matters
- Anyone reading medical content online is entitled to know how it was produced, and most sites in this space simply do not say. Being able to see the process is what makes it reasonable to trust a page that tells you something is unknown.
- It also sets an expectation you can hold the site to. A documented process is checkable; a claim of rigour is not.
How a record is built
Every entry begins from primary and authoritative sources: regulator documents, product labelling, trial registry records, and published studies located as specific documents. Search-result pages and aggregator listings are not accepted as sources, because they verify nothing and can change beneath a citation.
Each factual statement is mapped to the specific source that supports it, together with a short description of what that source establishes. When no source supports a statement, the statement is removed rather than softened. This is why records routinely say that something has not been examined in people; that sentence is the honest output of the process rather than a disclaimer bolted on afterwards.
What review covers
Content is reviewed on two axes. Medical review examines whether statements about biology, evidence and safety are accurate and appropriately hedged. Compliance review examines whether regulatory categories are stated correctly, whether anything reads as an offer or a promise, and whether required distinctions are preserved.
Review is recorded at the level of a defined packet of pages, bound to the exact content that was reviewed. Approval is deliberately separate from publication: recording an approval does not make a page indexable. Release is a second, explicit action, so content can be reviewed and still held back.
What invalidates an approval
Each page carries a hash computed from its material content — the claims, sources, safety statements, regulatory notes and definitions. Presentation-only changes such as an image or a navigation link do not alter it. A material edit does, and a changed hash invalidates the recorded approval for that page alone rather than for everything reviewed alongside it.
The practical consequence is that content cannot be quietly amended after approval. Either the text matches what was reviewed or the system reports that it no longer does, and re-review is required before that page can be treated as approved again.
How updates happen
Evidence changes, regulatory positions change, and both are expected. Records carry the date they were last written and the date review was recorded, so a reader can judge how current a page is rather than having to assume. Sources carry the date the document was last accessed and confirmed.
When a regulatory position moves or new human evidence appears, affected records are revised, which invalidates their approval and returns them to review. That is slower than editing a page in place, and the delay is the point: the alternative is content whose review status no longer describes what is actually on the page.
Definitions
Primary source
The original document reporting a finding or setting a regulatory position, rather than a summary of it.
Claim-to-source mapping
An explicit link between each factual statement and the specific source supporting it.
It makes a page checkable rather than merely confident.
Material hash
A fingerprint of a page's reviewable content, used to detect edits that invalidate a recorded approval.
Approval versus release
Approval records that review happened. Release is the separate decision to publish and allow indexing.
What is reasonably established
- Regulator documents and product labelling are authoritative sources for regulatory status.
- Trial registries and published studies are the appropriate primary sources for statements about human evidence.
- Advertising and health claims are expected to be substantiated by evidence concerning the product and outcome claimed.
What is not established
- That a review process makes any individual substance appropriate for any individual reader.
- That physician review of educational content constitutes medical advice or a clinical evaluation.
- That approval of content confers any regulatory status on the substances described.
Safety context
- Educational review is not a substitute for individual clinical evaluation, and no page here is written for a specific person.
- Where evidence is absent, records state the absence rather than filling it with mechanism or inference.
- Suspected harms from any medicine or preparation can be reported to the FDA through MedWatch.
Regulatory framing
Compliance review exists specifically to keep these categories separate on every page. A record must state which category a substance occupies and must not let physician involvement, review, or careful writing imply that an unapproved use has become an approved one.
Frequently asked questions
Does physician review mean the content is medical advice?
No. Review checks that educational statements are accurate and appropriately qualified. Advice is specific to a person and follows an evaluation, which a published page cannot perform.
What happens if a page is edited after review?
A material edit changes that page's content hash, which invalidates its recorded approval and returns it for re-review. Presentation-only changes do not.
Why do some pages say so little about benefit?
Because for many substances there is little human evidence about benefit to report. Stating that plainly is the accurate result of the process rather than an omission.
Sources
- Human Drug Compounding — U.S. Food and Drug Administration
- Investigational New Drug (IND) Application — U.S. Food and Drug Administration
- Understanding Unapproved Use of Approved Drugs "Off Label" — U.S. Food and Drug Administration
- Learn About Studies — ClinicalTrials.gov, U.S. National Library of Medicine
- Health Products Compliance Guidance — U.S. Federal Trade Commission
- Questions and Answers on Unapproved Drugs — U.S. Food and Drug Administration
This page is educational. It is not medical advice, not a prescription, and nothing here can be ordered. Compounded preparations are not FDA-approved. To ask a physician about your own situation, visit goal.md/peptides/connect or call or text 314-907-3103.
Medically reviewed by Michael Fitch, MD. Compliance review by Michael Mimlitz, MD. Last reviewed 2026-08-15.